nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A double-blind comparative study of doxazosin and prazosin in the treatment of essential hypertension
|
Fukiyama, Koshiro |
|
1991 |
121 |
1P2 |
p. 317-322 6 p. |
artikel |
2 |
A double-blind comparative study of doxazosin and prazosin when administered with β-blockers or diuretics
|
de Planque, Bernard A. |
|
1991 |
121 |
1P2 |
p. 304-311 8 p. |
artikel |
3 |
A long-term study of doxazosin in the treatment of mild or moderate essential hypertension in general medical practice
|
Manos, John |
|
1991 |
121 |
1P2 |
p. 346-351 6 p. |
artikel |
4 |
A multicenter study of doxazosin in the treatment of essential hypertension in France
|
Bonnet, Gérard |
|
1991 |
121 |
1P2 |
p. 335-340 6 p. |
artikel |
5 |
A multicenter study of doxazosin in the treatment of patients with mild or moderate essential hypertension and concomitant intermittent claudication
|
Catalano, Maria |
|
1991 |
121 |
1P2 |
p. 367-371 5 p. |
artikel |
6 |
An evaluation of the efficacy and safety of doxazosin in hypertension associated with renal dysfunction
|
Miura, Yukio |
|
1991 |
121 |
1P2 |
p. 381-388 8 p. |
artikel |
7 |
An open, noncomparative study of doxazosin in essential hypertension: Experience in general practice in the Netherlands
|
Naber, Frederick B. |
|
1991 |
121 |
1P2 |
p. 273-279 7 p. |
artikel |
8 |
Cardiovascular disease risk profiles
|
Anderson, Keaven M. |
|
1991 |
121 |
1P2 |
p. 293-298 6 p. |
artikel |
9 |
Clinical experience with doxazosin in general medical practice in New Zealand
|
Maslowski, Andrew H. |
|
1991 |
121 |
1P2 |
p. 323-328 6 p. |
artikel |
10 |
Clinical experience with doxazosin in general medical practice in the Netherlands
|
Harmse, Daniel P. |
|
1991 |
121 |
1P2 |
p. 341-345 5 p. |
artikel |
11 |
Double-blind comparison of doxazosin and enalapril in patients with mild or moderate essential hypertension
|
Wessels, Franz |
|
1991 |
121 |
1P2 |
p. 299-303 5 p. |
artikel |
12 |
Doxazosin and atenolol as monotherapy in mild and moderate hypertension: A randomized, parallel study with a three-year follow-up
|
Talseth, Tore |
|
1991 |
121 |
1P2 |
p. 280-285 6 p. |
artikel |
13 |
Doxazosin: A study in a cohort of patients with hypertension in general practice—An interim report
|
Langdon, Christopher G. |
|
1991 |
121 |
1P2 |
p. 268-273 6 p. |
artikel |
14 |
Doxazosin for the treatment of chronic congestive heart failure: Results of a randomized double-blind and placebo-controlled study
|
DiBianco, Robert |
|
1991 |
121 |
1P2 |
p. 372-380 9 p. |
artikel |
15 |
Doxazosin in the treatment of essential hypertension in general medical practice in Latin America
|
Silva, Honorio |
|
1991 |
121 |
1P2 |
p. 329-335 7 p. |
artikel |
16 |
Doxazosin in the treatment of mild or moderate essential hypertension: An echocardiographic study
|
Corral, JoséLuis |
|
1991 |
121 |
1P2 |
p. 352-356 5 p. |
artikel |
17 |
Echocardiographic assessment of doxazosin on left ventricular mass in patients with essential hypertension
|
Monsalve, Pedro |
|
1991 |
121 |
1P2 |
p. 356-361 6 p. |
artikel |
18 |
Effects of doxazosin on serum lipids: A review of the clinical data and molecular basis for altered lipid metabolism
|
Pool, James L. |
|
1991 |
121 |
1P2 |
p. 251-259 9 p. |
artikel |
19 |
Efficacy and safety of doxazosin in the treatment of patients with mild or moderate essential hypertension and elevated levels of cholesterol
|
Taylor, Stanley H. |
|
1991 |
121 |
1P2 |
p. 362-366 5 p. |
artikel |
20 |
Efficacy of doxazosin in specific hypertensive patient groups
|
Taylor, Stanley H. |
|
1991 |
121 |
1P2 |
p. 286-292 7 p. |
artikel |
21 |
Evidence of an antiplatelet aggregation action of doxazosin in patients with hypertension: An ex vivo study
|
Hernandez Hernandez, Rafael |
|
1991 |
121 |
1P2 |
p. 395-401 7 p. |
artikel |
22 |
Group discussion
|
|
|
1991 |
121 |
1P2 |
p. 249-250 2 p. |
artikel |
23 |
Group discussion
|
|
|
1991 |
121 |
1P2 |
p. 259-260 2 p. |
artikel |
24 |
Group discussion
|
|
|
1991 |
121 |
1P2 |
p. 402-405 4 p. |
artikel |
25 |
Group discussion
|
|
|
1991 |
121 |
1P2 |
p. 292- 1 p. |
artikel |
26 |
Introduction
|
Sever, Peter S. |
|
1991 |
121 |
1P2 |
p. 245- 1 p. |
artikel |
27 |
Management of multiple risk factors for coronary heart disease in patients with hypertension
|
Poulter, Neil |
|
1991 |
121 |
1P2 |
p. 246-249 4 p. |
artikel |
28 |
Preliminary results of the Norwegian doxazosin postmarketing surveillance study: A twelveweek experience
|
Holme, Ingar |
|
1991 |
121 |
1P2 |
p. 260-267 8 p. |
artikel |
29 |
Summary
|
Sever, Peter S. |
|
1991 |
121 |
1P2 |
p. 406- 1 p. |
artikel |
30 |
The addition of doxazosin to the treatment regimen of patients with hypertension not adequately controlled by by β-blockers
|
Englert, Rudolf Georg |
|
1991 |
121 |
1P2 |
p. 311-316 6 p. |
artikel |
31 |
The effect of doxazosin on platelet aggregation in normotensive subjects and patients with hypertension: An in vitro study
|
Hernandez Hernandez, Rafael |
|
1991 |
121 |
1P2 |
p. 389-394 6 p. |
artikel |